Multivitamins (Pabrinex IV): Hospital supply issue
The supplier, Max Health, advises that there will be long-term delays to Pabrinex IV multivitamins. (Listed as an example brand in the HML)
11 July 2024 Update
Max Health have secured stock of an alternative, Syndrex. It is an identical formulation to Pabrinex and is currently supplied in the UK. We will add more details as they are available.
About this supply issue
Max Health, the supplier, advises that there is a supply interruption because of a change of manufacturing site. This will not be resolved until September 2025.
There is enough stock available to last until September 2024. This stock is on allocation to manage an equitable distribution of the remaining product.
HML Online listing for Pabrinex IV(external link)
Alternative
Max Health have secured stock of an alternative, Syndrex. It is an identical formulation to Pabrinex and is currently supplied in the UK. We will add more details as they are available.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)